BIT's 9th Annual World Cancer Congress (WCC-2016)

BIT’s 9th Annual World Cancer Congress -2016 (WCC-2016) will be held on 14-16, May 2016 in Shanghai, China.

WCC-2016 provides a unique and ideal opportunity for a broad spectrum of researchers, clinicians and other health professionals to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer in the world. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better diagnosis and treatment of cancer patients.

WCC-2016 enables presenters and delegates to enjoy the state of the art oral and poster presentations covering the in-depth findings into the cause and processes of the disease and recent advances in clinical practice, from prevention to diagnosis, treatment and care.

We hope your participation would contribute to your professional development and relationships. Wish you enjoy the conference.

Scientific Program
Stream 1
Opening Ceremony and Keynote Forum
08:30-12:00, May 14, 2016
Stream 2
(Parallel Sessions) Breaking Research to Understand Cancers
08:30-17:00, May 14-16, 2016
Stream 4
(Parallel Sessions) Anticancer Drug Development
08:30-17:00, May 14-16, 2016
Stream 5
(Parallel Sessions) Anticancer Drug Development
08:30-17:00, May 14-16, 2016
Stream 6
08:30-17:00, May 14-16, 2016
Stream 7
Social Events
08:30-17:00, May 14-16, 2016
International Renowned Speakers Dr. Thomas Tursz, Professor & Honorary Director, Institut Gustave Roussy, France
Dr. Vladimir LAZAR, Founder and Chief Operating Officer, WIN consortium, France Dr. Alexandra Levine, Chief Medical Officer, Melinda and Norman Payson Professor of Medicine and Professor of Hematology/Transplantation, City of Hope National Medical Center, USA
Dr. Ivan Gout, Professor, University College London, UK Dr. Gerd Birkenmeier, Professor, Institute of Biochemistry, University of Leipzig, Germany Dr. Robert T Chatterton, Professor, Northwestern University Feinberg School of Medicine, USA
Dr. Adhip P. N. Majumdar, Professor & Senior Research Scientist, VA Medical Center/Karmanos Cancer Institute, Wayne State University, USA Dr. Rajesh C. Shrotriya, CEO, Spectrum Pharmaceuticals, Inc., USA Dr. Wim Vanden Berghe, Professor, University Antwerp, Belgium
Dr. Andreas Mandelis, Professor and Director, University of Toronto, Canada Dr. Senyon Choe, Professor of Biology, University of California San Diego, USA Dr. Belamy Cheung, Manager & Senior Lecturer, Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Australia
Dr. Mohamed Aziz, Senior Attending Pathologist/Cytopathologist, North Shore-LIJ Health System, Hofstra North Shore-LIJ School of Medicine, USA Dr. Gian Otto Heinrich Dorta, Professor, CHUV, University Hospital of Lausanne, Switzerland Dr. Antonia Dimitrakopoulou-Strauss, Deputy Head, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Germany
Dr. Xaveer Van Ostade, Professor, Departement of Biomedical Sciences, University of Antwerp, Belgium Dr. Johannes Haybaeck, Professor, Institute of Pathology, Medical University of Graz, Austria Dr. Reza-Thierry ELAIDI, Director of Clinical Operations, ARTIC, France
Dr. Thomas Grundström, Professor, Department of Molecular Biology, Umeå University, Sweden Dr. Manfred George Krukemeyer, Chairman, Department of Radio-Oncology, Paracelsus-Hospital, Germany Dr. Arun K. Rishi, Professor, Department of Oncology, Karmanos Cancer Institute,  Wayne State University, USA
Dr. Olivier Pardo, Team Leader & Lecturer, Division of Cancer, Imperial College, UK Ms. Donna M. O’Brien, President and CEO, Strategic Visions in Healthcare, LLC., USA Dr. K.S. Rangappa, Professor of Chemistry & Vice-Chancellor, University of Mysore Crawford Hall, India
Dr. Renata Pasqualini, Professor of Internal Medicine & Associate Director, Translational Research, University of New Mexico Cancer Center, USA Dr. Qian-Yun Zhang, Professor of Pathology, University of New Mexico, USA Dr. Xiaoyan Jiang, Professor, Medical Genetics, University of British Columbia & Distinguished Scientist, Terry Fox Laboratory, BC Cancer Research Centre, Canada
Dr. Vikash Sewram, Director & Professor, African Cancer Institute & Stellenbosch University, South Africa Dr. Yanping Zhang, Professor, The University of North Carolina at Chapel Hill, USA Dr. Yi Charlie Chen, Professor of Biology, Alderson Broaddus University, USA
Previous Event Report

The 9th Annual World Cancer Congress (WCC-2016) was successfully held on May 14-16, Shanghai, China. More than 400 participants from over 43 countries and areas have attended the WCC-2016.

As the keynote speakers, Dr. Marek Krawczyk, Head, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Poland; Dr. Vladimir Lazar, Founder and Chief Operating Officer, WIN Consortium, France; Dr. Alexandra M. Levine, Chief Medical Officer, City of Hope National Medical Center, USA and Dr. Yong Qian, Chief Scientific Officer & Chairman, BioMedicure, USA & China attended the opening ceremony and the Keynote Forum. Depending on the warmly support and good suggestions from all of the participants, we are definitely sure BIT's 10th World Cancer Congress-2017, will be better and more successful than WCC-2016!

Exhibition and Poster

As part of the 2016 World Cancer Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.

Exhibitors' advantages
• The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.


Exhibition Date:
Set-up date: May 13, 2016
Show dates: May 14-16, 2016 09:00-18:00
Place: Shanghai, China

News Released

1. The world Well-known Overseas Cancer Research Center, e.g. Institut Gustave Roussy, City of Hope National Medical Center, UC San Diego Moores Cancer Center, The UT MD Anderson Cancer Center, University of Texas Health Science Center, German Cancer Research Center, University of New Mexico Cancer Center, BC Cancer Research Centre have sent representatives to attend the WCC-2016

2. Dr. Guo-Liang Jiang, CTO, Shanghai Proton and Heavy Ion Center, China has confirmed to attend WCC-2016

3. Dr. Alexandra Levine, Chief Medical Officer, City of Hope National Medical Center, USA has confirmed to attend WCC-2016

4. Dr. Vladimir LAZAR, Founder and Chief Operating Officer, WIN Consortium, France has confirmed to attend WCC-2016

5. Congratulations on the cooperation between WCC-2016, Shanghai and WIN-2016, Paris.

Hosting Organization

Information Research Center of International Talents, SAFEA

Operating Organization

BIT Congress Inc.

Foreign Experts Databank of SAFEA-Dalian Branch

International Honorary Chairman

Dr. Thomas Tursz
Professor & Honorary Director
Institut Gustave Roussy, France

Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2015-2016 BIT Congress Inc.